Cited by 610Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.

Imaging the evolution and pathophysiology of Alzheimer disease

Open access

Jagust, William·2018·Nature Reviews Neuroscience

DOI 10.1038/s41583-018-0067-3PMC PMC7032048

Open this paper in CoChat — free account

Abstract

Technologies for imaging the pathophysiology of Alzheimer disease (AD) now permit studies of the relationships between the two major proteins deposited in this disease - amyloid-β (Aβ) and tau - and their effects on measures of neurodegeneration and cognition in humans. Deposition of Aβ in the medial parietal cortex appears to be the first stage in the development of AD, although tau aggregates in the medial temporal lobe (MTL) precede Aβ deposition in cognitively healthy older people. Whether aggregation of tau in the MTL is the first stage in AD or a fairly benign phenomenon that may be transformed and spread in the presence of Aβ is a major unresolved question. Despite a strong link between Aβ and tau, the relationship between Aβ and neurodegeneration is weak; rather, it is tau that is associated with brain atrophy and hypometabolism, which, in turn, are related to cognition. Although there is support for an interaction between Aβ and tau resulting in neurodegeneration that leads to dementia, the unknown nature of this interaction, the strikingly different patterns of brain Aβ and tau deposition and the appearance of neurodegeneration in the absence of Aβ and tau are challenges to this model that ultimately must be explained.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41583-018-0067-3

Cites

213 of 213 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Self-citation
What is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814

Show all 213 references

Sorted by citations

Items 101–200 of 610

Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats
Rodríguez, M. H., Arciniega-Martínez, I. M., García-Marín, I. D., Correa‐Basurto, J., & Rosales‐Hernández, M. C. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02009-x · Cited by 51
Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
Rani, S., Dhar, S. B., Khajuria, A., Gupta, D., Jaiswal, P. K., Singla, N., Kaur, M., Singh, G., & Barnwal, R. P. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01330-y · Cited by 48
Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer’s disease
Sang, Z., Song, Q., Cao, Z., Deng, Y., Tan, Z., & Zhang, L. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113310 · Cited by 46
What’s the cut-point?: a systematic investigation of tau PET thresholding methods
Weigand, A. J., Maaß, A., Eglit, G. L., & Bondi, M. W. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00986-w · Cited by 49
Successful cognitive aging is associated with thicker anterior cingulate cortex and lower tau deposition compared to typical aging
Pezzoli, S., Giorgio, J., Martersteck, A., Dobyns, L., Harrison, T. M., & Jagust, W. J. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13438 · Cited by 42
Self-citation
Gut Microbiota: Critical Controller and Intervention Target in Brain Aging and Cognitive Impairment
Li, H., Ni, J., & Qing, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.671142 · Cited by 44
Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer’s disease – Evidence from an MRI-based meta-analysis
Mieling, M., Meier, H., & Bunzeck, N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105393 · Cited by 42
Association of Presynaptic Loss with Alzheimer's Disease and Cognitive Decline
Lan, G., Cai, Y. Q., Li, A., Liu, Z., Ma, S., Guo, T., & Initiative, A. D. N. (2022) · Annals of Neurology · doi:10.1002/ana.26492 · Cited by 42
Alzheimer’s Pathology Is Associated with Dedifferentiation of Intrinsic Functional Memory Networks in Aging
Cassady, K. E., Adams, J. N., Chen, X., Maaß, A., Harrison, T. M., Landau, S. M., Baker, S. L., & Jagust, W. J. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab122 · Cited by 46
Self-citation
Navigating Early Alzheimer's Diagnosis: A Comprehensive Review of Diagnostic Innovations
Juganavar, A., Joshi, A., & Shegekar, T. (2023) · Cureus · doi:10.7759/cureus.44937 · Cited by 47
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Borrego-Ruiz, A., & Borrego, J. J. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112497 · Cited by 43
Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults
Pereira, J. B., Harrison, T. M., Joie, R. L., Baker, S. L., & Jagust, W. J. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04669-x · Cited by 40
Self-citation
A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation
Giorgio, J., Jagust, W. J., Baker, S. L., Landau, S. M., Peter Tiňo, B., Kourtzi, Z., & Initiative, A. D. N. (2022) · Nature Communications · doi:10.1038/s41467-022-28795-7 · Cited by 40
Self-citation
On the design of convolutional neural networks for automatic detection of Alzheimer's diseasePreprint
Liu, S., Yadav, C., Fernandez‐Granda, C., & Razavian, N. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1911.03740 · Cited by 41
Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation
Silva, D. F., Empadinhas, N., Cardoso, S. M., & Esteves, A. R. (2022) · Antioxidants · doi:10.3390/antiox11112141 · Cited by 44
Trajectories and contributing factors of neural compensation in healthy and pathological aging
Bunzeck, N., Steiger, T. K., Krämer, U. M., Luedtke, K., Marshall, L., Obleser, J., & Tune, S. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105489 · Cited by 43
From Plaques to Pathways in Alzheimer’s Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis
Kazemeini, S., Nadeem-Tariq, A., Shih, R., Rafanan, J., Ghani, N., & Vida, T. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111720 · Cited by 41
Thymosin β4 reverses phenotypic polarization of glial cells and cognitive impairment via negative regulation of NF-κB signaling axis in APP/PS1 mice
Wang, M., Feng, L.-R., Li, Z., Ma, K., Chang, K.-W., Chen, X., Yang, P., Ji, S., Ma, Y., Han, H., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02166-3 · Cited by 37
Associations of cortical iron accumulation with cognition and cerebral atrophy in Alzheimer’s disease
Yang, A., Du, L., Gao, W., Liu, B., Chen, Y., Wang, Y., Liu, X., Lv, K., Zhang, W., Xia, H., et al. (2022) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-7 · Cited by 38
Improving PET Imaging Acquisition and Analysis With Machine Learning: A Narrative Review With Focus on Alzheimer's Disease and Oncology
Duffy, I. R., Boyle, A. J., & Vasdev, N. (2019) · Molecular Imaging · doi:10.1177/1536012119869070 · Cited by 38
Brain metabolic signatures across the Alzheimer’s disease spectrum
Sala, A., Caprioglio, C., Santangelo, R., Vanoli, E. G., Iannaccone, S., Magnani, G., & Perani, D. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04559-2 · Cited by 37
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
Llibre‐Guerra, J. J., Li, Y., Schindler, S. E., Gordon, B. A., Fagan, A. M., Morris, J. C., Benzinger, T. L. S., Hassenstab, J. J., Wang, G., Allegri, R., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17126 · Cited by 40
Relationships Between Cognition and Neuropathological Tau in Alzheimer’s Disease Assessed by 18 F Flortaucipir PET
Devous, M. D., Fleisher, A., Pontecorvo, M. J., Lu, M., Siderowf, A. D., Navitsky, M. A., Kennedy, I. A., Southekal, S. S., Harris, T. S., & Mintun, M. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200808 · Cited by 38
A Machine Learning–Based Approach to Discrimination of Tauopathies Using [ 18F ] PM‐PBB3 PET Images
Endo, H., Tagai, K., Ono, M., Ikoma, Y., Oyama, A., Matsuoka, K., Kokubo, N., Hirata, K., Sano, Y., Oya, M., et al. (2022) · Movement Disorders · doi:10.1002/mds.29173 · Cited by 36
Neural stem cell-derived exosomes promote mitochondrial biogenesis and restore abnormal protein distribution in a mouse model of Alzheimer's disease
Li, B., Chen, Y., Zhou, Y., Feng, X., Gu, G., Han, S., Cheng, N., Sun, Y., Zhang, Y., Cheng, J., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385839 · Cited by 42
Functional connectome through the human life span
Sun, L., Zhao, T., Liang, X., Xia, M., Li, Q., Liao, X., Gong, G., Wang, Q., Pang, C., Yu, Q., et al. (2024) · Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · doi:10.58530/2024/1294 · Cited by 42
Near-Infrared-Active Copper Bismuth Oxide Electrodes for Targeted Dissociation of Alzheimer’s β-Amyloid Aggregates
Heo, Y., Kim, K., Kim, J., Jang, J., & Park, C. B. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c02349 · Cited by 36
The application of multifunctional nanomaterials in Alzheimer’s disease: A potential theranostics strategy
Xu, Y., Zhao, M.-N., Zhou, D., Zheng, T., & Zhang, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111360 · Cited by 38
Defective Autophagy and Mitophagy in Alzheimer’s Disease: Mechanisms and Translational Implications
Chen, J., He, H., Ye, Q., Feng, F., Wang, W., Gu, Y., Han, R., & Xie, C. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02487-7 · Cited by 37
Enhancement of Insulin/PI3K/Akt Signaling Pathway and Modulation of Gut Microbiome by Probiotics Fermentation Technology, a Kefir Grain Product, in Sporadic Alzheimer’s Disease Model in Mice
Sayed, N. S. E., Kandil, E. A., & Ghoneum, M. H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.666502 · Cited by 38
D-chiro-inositol increases antioxidant capacity and longevity of Caenorhabditis elegans via activating Nrf-2/SKN-1 and FOXO/DAF-16
Shi, L., Yu, X., Li, H., Wu, G.-S., & Luo, H. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112145 · Cited by 35
Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer’s disease
Yu, M., Risacher, S. L., Nho, K. T., Wen, Q., Oblak, A. L., Unverzagt, F. W., Apostolova, L. G., Farlow, M. R., Brosch, J. R., Clark, D. G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113691 · Cited by 36
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Nabizadeh, F., Seyedmirzaei, H., & Karami, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-66211-w · Cited by 36
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
Tobin, A. B. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01007-1 · Cited by 38
Diagnosis and treatment of cognitive impairment
Arnim, C. A. F. V., Bartsch, T., Jacobs, A. H., Holbrook, J. A., Bergmann, P., Zieschang, T., Polidori, M. C., & Dodel, R. C. (2019) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-019-01560-0 · Cited by 36
Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology
Han, F., Lee, J., Chen, X., Ziontz, J., Ward, T. J., Landau, S. M., Baker, S. L., Harrison, T. M., Jagust, W. J., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14296 · Cited by 42
Self-citation
Reduced Repetition Suppression in Aging is Driven by Tau–Related Hyperactivity in Medial Temporal Lobe
Adams, J. N., Maaß, A., Berron, D., Harrison, T. M., Baker, S. L., Thomas, W. P., Stanfill, M., & Jagust, W. J. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2504-20.2021 · Cited by 34
Self-citation
Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer’s disease
Sang, Z., Song, Q., Cao, Z., Deng, Y., & Zhang, L. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1993845 · Cited by 33
Reelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy
Rossi, D., Gruart, A., Contreras-Murillo, G., Muhaisen, A., Ávila, J., Delgado-García, J. M., Pujadas, L., & Soriano, E. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101743 · Cited by 30
β-Lapachone attenuates cognitive impairment and neuroinflammation in beta-amyloid induced mouse model of Alzheimer's disease
Mokarizadeh, N., Karimi, P., Erfani, M., Sadigh‐Eteghad, S., Maroufi, N. F., & Rashtchizadeh, N. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106300 · Cited by 35
Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer’s disease
Wang, K., Shi, J., Zhou, Y. M., He, Y., Mi, J., Yang, J. L., Liu, S., Tang, X., Liu, W., Tan, Z., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104879 · Cited by 32
Association of APOE -ε4, Osteoarthritis, β-Amyloid, and Tau Accumulation in Primary Motor and Somatosensory Regions in Alzheimer Disease
Du, J., Li, A., Shi, D., Chen, X., Wang, Q., Liu, Z., Sun, K., Guo, T., & Initiative, A. D. N. (2023) · Neurology · doi:10.1212/wnl.0000000000207369 · Cited by 35
The neuroprotective and neural circuit mechanisms of acupoint stimulation for cognitive impairment
Zhang, Z., Chen, L., Guo, Y., Li, D., Zhang, J., Liu, L., Fan, W., Guo, T., Qin, S., Zhao, Y., et al. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00707-x · Cited by 33
Differences in Alzheimer’s Disease and Related Dementias Pathology Among African American and Hispanic Women: A Qualitative Literature Review of Biomarker Studies
Royse, S. K., Cohen, A. D., Snitz, B. E., & Rosano, C. (2021) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2021.685957 · Cited by 31
Relationship between tau, neuroinflammation and atrophy in Alzheimer's disease: The NIMROD study
Su, L., Surendranathan, A., Huang, Y., Bevan-Jones, W. R., Passamonti, L., Hong, Y. T., Arnold, R. J., Rodríguez, P. V., Wang, Y., Mak, E., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.10.006 · Cited by 32
Exposure to negative socio-emotional events induces sustained alteration of resting-state brain networks in older adults
Baez-Lugo, S., Deza-Araujo, Y. I., Maradan, C., Collette, F., Antoine Lutz, A., Marchant, N. L., Chételat, G., Vuilleumier, P. O., Klimecki, O., Arenaza‐Urquijo, E. M., et al. (2023) · Nature Aging · doi:10.1038/s43587-022-00341-6 · Cited by 31
The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [ 18 F]MK6240 Tau PET in Target Regions
Tissot, C., Servaes, S., Lussier, F. Z., Ferrari‐Souza, J. P., Therriault, J., Ferreira, P. C. L., Bezgin, G., Bellaver, B., Leffa, D. T., Mathotaarachchi, S. S., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264434 · Cited by 30
Alzheimer's disease: Potential pathogenesis and imaging findings
Zhang, Y., Zhang, C., Liu, J., & Shao, H. (2023) · Open Research (University of Surrey) · doi:10.1002/viw.20230025 · Cited by 33
Association between periodontitis and Alzheimer's disease: A narrative review
Seyedmoalemi, M., & Saied‐Moallemi, Z. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.12.004 · Cited by 29
The role of magnetic fields in neurodegenerative diseases
Riancho, J., de la Torre, J. R. S., Paz‐Fajardo, L., Limia, C., Santurtún, A., Cifra, M., Kourtidis, K., & Fdez-Arróyabe, P. (2020) · International Journal of Biometeorology · doi:10.1007/s00484-020-01896-y · Cited by 29
Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease
Dang, M., Chen, Q., Zhao, X. B., Chen, K., Li, X., Zhang, J., Lu, J., Ai, L., Chen, Y., & Zhang, Z. (2022) · Human Brain Mapping · doi:10.1002/hbm.26043 · Cited by 31
The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
Lu, J., Zhang, Z., Wu, P., Liang, X., Zhang, H., Hong, J., Clement, C., Yen, T., Ding, S., Wang, M., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103416 · Cited by 31
How Do Modifiable Risk Factors Affect Alzheimer’s Disease Pathology or Mitigate Its Effect on Clinical Symptom Expression?
Ourry, V., Binette, A. P., St‐Onge, F., Strikwerda‐Brown, C., Chagnot, A., Poirier, J., Breitner, J. C. S., Arenaza‐Urquijo, E. M., Rabin, J. S., Buckley, R. F., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.09.003 · Cited by 30
Alzheimer’s Disease: From Amyloid to Autoimmune Hypothesis
Arshavsky, Y. I. (2020) · The Neuroscientist · doi:10.1177/1073858420908189 · Cited by 28
Addressing the missing data challenge in multi-modal datasets for the diagnosis of Alzheimer’s disease
Aghili, M., Tabarestani, S., & Adjouadi, M. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2022.109582 · Cited by 31
Engineering NIR-II luminescent lanthanide nanoprobes for imaging brain diseases in vivo
Du, Y., Ni, S., Ma, Q., Song, X., & Yang, H. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215401 · Cited by 29
Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β
Huang, Z., Yan, Q., Wang, Y., Zou, Q., Li, J., Liu, Z., & Cai, Z. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200519 · Cited by 28
Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin‐Induced Sporadic Alzheimer’s Disease in Mice
Sayed, N. S. E., Kandil, E. A., & Ghoneum, M. H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5525306 · Cited by 31
Retracted
Positive Effects of Education on Cognitive Functioning Depend on Clinical Status and Neuropathological Severity
Jansen, M. G., Geerligs, L., Claassen, J. A. H. R., Overdorp, E. J., Brazil, I. A., Kessels, R. P. C., & Oosterman, J. M. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.723728 · Cited by 28
Multimodal data integration via mediation analysis with high‐dimensional exposures and mediators
Zhao, Y., Li, L., & Initiative, A. D. N. (2022) · Human Brain Mapping · doi:10.1002/hbm.25800 · Cited by 25
Cucurbituril-Oriented Nanoplatforms in Biomedical Applications
Cheng, G., Luo, J., Liu, Y., Chen, X., Wu, Z., & Chen, T. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01061 · Cited by 29
Morphological integration of the human brain across adolescence and adulthood
Nadig, A., Seidlitz, J., McDermott, C. L., Liu, S., Bethlehem, R. A. I., Moore, T. M., Mallard, T. T., CLASEN, L. S., Blumenthal, J. D., Lalonde, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023860118 · Cited by 27
Classification of Initial Stages of Alzheimer’s Disease through Pet Neuroimaging Modality and Deep Learning: Quantifying the Impact of Image Filtering Approaches
Tufail, A. B., Ma, Y., Kaabar, M. K. A., Rehman, A. U., Khan, R., & Cheikhrouhou, O. (2021) · Mathematics · doi:10.3390/math9233101 · Cited by 28
Prediction and Modeling of Neuropsychological Scores in Alzheimer’s Disease Using Multimodal Neuroimaging Data and Artificial Neural Networks
Hojjati, S. H., Abbas Babajani-feremi, A., & Initiative, T. A. D. N. (2022) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2021.769982 · Cited by 28
Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome
Martini, A. C., Gross, T. J., Head, E., & Mapstone, M. E. (2022) · Neuron · doi:10.1016/j.neuron.2022.04.001 · Cited by 26
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology
Gouilly, D., Rafiq, M., Nogueira, L., Salabert, A., Payoux, P., Péran, P., & Pariente, J. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.006 · Cited by 31
End-to-end automatic pathology localization for Alzheimer’s disease diagnosis using structural MRI
Cao, G., Zhang, M., Wang, Y., Zhang, J., Han, Y., Xu, X., Huang, J., & Kang, G. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107110 · Cited by 28
FDG‐PET markers of heterogeneity and different risk of progression in amnestic MCI
Caminiti, S., Francesco, S. D., Tondo, G., Galli, A., Redolfi, A., & Perani, D. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13385 · Cited by 27
Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease
Drakontaeidi, A., & Pontiki, E. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010582 · Cited by 28
The Effects of Amyloid and Tau on Functional Network Connectivity in Older Populations
Wales, R. M., & Leung, H.-C. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0902 · Cited by 26
Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression
Takamiya, A., Casteele, T. V., Koole, M. J. B., Winter, F. D., Bouckaert, F., den Stock, J. V., Sunaert, S. G., Dupont, P. J., Vandenberghe, R. R., Laere, K. V., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95206-0 · Cited by 27
Hippocampus- and thalamus-related fiber-specific white matter reductions in mild cognitive impairment
Yu, Z., Si, X., Chen, Y., Chao, Y., Lin, C., Li, S., Zhang, X., Ming, D., & Li, Q. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab407 · Cited by 26
Orientin Prolongs the Longevity of Caenorhabditis elegans and Postpones the Development of Neurodegenerative Diseases via Nutrition Sensing and Cellular Protective Pathways
Qu, Y., Shi, L., Liu, Y., Huang, L., Luo, H., & Wu, G.-S. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8878923 · Cited by 26
Tanshinone IIA ameliorates Aβ transendothelial transportation through SIRT1-mediated endoplasmic reticulum stress
Wan, C., Liu, X.-Q., Chen, M., Ma, H., Wu, G.-L., Qiao, L., Cai, Y.-F., & Zhang, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03889-y · Cited by 27
Aging and Alzheimer’s disease have dissociable effects on local and regional medial temporal lobe connectivity
Hrybouski, S., Das, S. R., Xie, L., Wisse, L. E. M., Kelley, M., Lane, J., Sherin, M., DiCalogero, M., Nasrallah, I. M., Detre, J. A., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad245 · Cited by 38
Fecal Microbiota Transplantation in Alzheimer’s Disease: Mechanistic Insights Through the Microbiota–Gut–Brain Axis and Therapeutic Prospects
Ren, J., Wang, Q., Hong, H., & Tang, C. (2025) · Microorganisms · doi:10.3390/microorganisms13081956 · Cited by 28
Intermittent Hypoxia Training Prevents Deficient Learning-Memory Behavior in Mice Modeling Alzheimer's Disease: A Pilot Study
Ryou, M., Chen, X., Cai, M., Wang, H., Jung, M. E., Metzger, D. B., Mallet, R. T., & Shi, X. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.674688 · Cited by 26
Modulation of Cortical and Hippocampal Functional MRI Connectivity Following Transcranial Alternating Current Stimulation in Mild Alzheimer Disease
Wang, T., Yan, S., Shan, Y., Xue, H., Xing, Y., Bi, S., Chen, Z., Xi, H., Qi, Z., Tang, Y., et al. (2025) · Radiology · doi:10.1148/radiol.241463 · Cited by 24
Content-specific vulnerability of recent episodic memories in Alzheimer's disease
Grande, X., Berron, D., Maaß, A., Bainbridge, W. A., & Düzel, E. (2021) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2021.107976 · Cited by 27
Revisiting PFA-mediated tissue fixation chemistry: FixEL enables trapping of small molecules in the brain to visualize their distribution changes
Nonaka, H., Mino, T., Sakamoto, S., Oh, J. H., Watanabe, Y., Ishikawa, M., Tsushima, A., Amaike, K., Kiyonaka, S., Tamura, T., et al. (2022) · Chem · doi:10.1016/j.chempr.2022.11.005 · Cited by 24
Tau accumulation and atrophy predict amyloid independent cognitive decline in aging
Fonseca, C. S., Baker, S. L., Dobyns, L., Janabi, M., Jagust, W. J., & Harrison, T. M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13654 · Cited by 25
Self-citation
Involvement of amyloid proteins in the formation of biofilms in the pathogenic yeast Candida albicans
Mourer, T., Ghalid, M. E., d’Enfert, C., & Bachellier‐Bassi, S. (2021) · Research in Microbiology · doi:10.1016/j.resmic.2021.103813 · Cited by 25
MicroRNA-455–5p/CPEB1 pathway mediates Aβ-related learning and memory deficits in a mouse model of Alzheimer’s disease
Xiao, G., Chen, Q., & Zhang, X. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.10.008 · Cited by 25
Optimizing quantification of MK6240 tau PET in unimpaired older adults
Harrison, T. M., Ward, T. J., Murphy, A., Baker, S. L., Dominguez, P. A., Koeppe, R. A., Vemuri, P., Lockhart, S. N., Jung, Y., Harvey, D. J., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119761 · Cited by 25
Self-citation
Menthol-Modified Quercetin Liposomes with Brain-Targeting Function for the Treatment of Senescent Alzheimer’s Disease
Liu, W., Yu, Y., Zang, J., Liu, Y., Li, F.-R., Zhang, L., Guo, R., Kong, L., Ma, L.-Y., & Li, X. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00109 · Cited by 23
Air pollution: a latent key driving force of dementia
Mohammadzadeh, M., Khoshakhlagh, A. H., & Grafman, J. H. (2024) · BMC Public Health · doi:10.1186/s12889-024-19918-4 · Cited by 26
Pseudoginsenoside-F11 improves long-term neurological function and promotes neurogenesis after transient cerebral ischemia in mice
Yuan, L., Sun, S., Pan, X., Zheng, L., Li, Y., Yang, J., & Wu, C. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104586 · Cited by 23
Topographical Overlapping of the Amyloid-β and Tau Pathologies in the Default Mode Network Predicts Alzheimer’s Disease with Higher Specificity
Hojjati, S. H., Feiz, F., Ozoria, S., Razlighi, Q. R., & Initiative, F. T. A. D. N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210419 · Cited by 22
Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer’s Disease
Bhawal, R. P., Fu, Q., Anderson, E. T., Gibson, G. E., & Zhang, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413188 · Cited by 24
Novel benzodiazepine remimazolam tosylate delays neurodegeneration of aged mice via decreasing tau phosphorylation
Liu, X., Guo, L., Duan, B., Wu, J., & Wang, E. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.08.003 · Cited by 23
Aptamer conjugated polydopamine-coated gold nanoparticles as a dual-action nanoplatform targeting β-amyloid peptide for Alzheimer's disease therapy
Qin, J., Guan, Y., Li, Z., Guo, X., Zhang, M., Wang, D., & Tang, J. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01499h · Cited by 23
Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer’s Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes
Kim, S. H., Choi, K. Y., Park, Y., McLean, C., Park, J., Lee, J. H., Lee, K., Kim, B. C., Huh, Y. H., Lee, K. H., et al. (2021) · Cells · doi:10.3390/cells10102697 · Cited by 23
MicroRNAs in the pathophysiology of Alzheimer’s disease and Parkinson's disease: an overview
Khezri, M. R., Yousefi, K., Zolbanin, N. M., & Ghasemnejad‐Berenji, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02727-4 · Cited by 22
Distinct Factors Drive the Spatiotemporal Progression of Tau Pathology in Older Adults
Adams, J. N., Harrison, T. M., Maass, A., Baker, S. L., & Jagust, W. J. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1601-21.2021 · Cited by 22
Self-citation
Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer’s disease
Mi, J., He, Y., Yang, J., Zhou, Y., Zhu, G., Wu, A., Liu, W., & Sang, Z. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128574 · Cited by 22
Design, synthesis and evaluation of novel scutellarin and scutellarein-N,N-bis-substituted carbamate-l-amino acid derivatives as potential multifunctional therapeutics for Alzheimer’s disease
Wu, D., Chen, J., Luo, K., Li, H., Liu, T., Li, L., Dai, Z., Li, Y., Zhao, Y., & Fu, X. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105760 · Cited by 21
Connecting the Dots: The Cerebral Lymphatic System as a Bridge Between the Central Nervous System and Peripheral System in Health and Disease
Zhao, H., Sun, M., Zhang, Y., Kong, W., Fan, L., Wang, K., Xu, Q., Chen, B., Dong, J., Shi, Y., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0516 · Cited by 22
Exposure to surgery with general anaesthesia during adult life is not associated with increased brain amyloid deposition in older adults
Šprung, J., Warner, D. O., Knopman, D. S., Petersen, R. C., Mielke, M. M., Jack, C. R., Lowe, V. J., Martin, D. P., Hanson, A. C., Schroeder, D. R., et al. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.01.015 · Cited by 20
Tectochrysin increases stress resistance and extends the lifespan of Caenorhabditis elegans via FOXO/DAF-16
Lu, M., Tan, L., Zhou, X., Yang, Z., Zhu, Q. C., Chen, J., Luo, H., & Wu, G.-S. (2020) · Biogerontology · doi:10.1007/s10522-020-09884-w · Cited by 21
Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample
Ramos‐Miguel, A., Jones, A. A., Petyuk, V., Barakauskas, V., Barr, A. M., Leurgans, S. E., Jager, P. L. D., Casaletto, K. B., Schneider, J. A., Bennett, D. A., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02282-7 · Cited by 20

Authors: Jagust, W.
Affiliations: Lawrence Berkeley National Laboratory (US)
Corresponding author: Jagust, William
ORCID: Jagust, William
Venue: Nature Reviews Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2018-09-28
Volume: 19
Issue: 11
Pages: 687-700
ISSN: 1471-003X (ISSN-L)
1471-0048
DOI: 10.1038/s41583-018-0067-3
PMC: PMC7032048
OpenAlex: W2894357926
Cited by: 604
References: 213
Citations by year: 2026: 73 · 2025: 85 · 2024: 89 · 2023: 94 · 2022: 76 · 2021: 85 · 2020: 58 · 2019: 40 · 2018: 2
FWCI: 7.13
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Neuroscience (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute on Aging (R01AG045611, R01AG062542, P01AG019724, R01AG034570)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, amyloid-beta, tau protein, neurodegeneration, brain atrophy, hypometabolism, medial parietal cortex, medial temporal lobe, cognitive decline, dementia, disease progression
MeSH terms: Aging, Alzheimer Disease, Brain, Humans, Amyloid beta-Peptides, tau Proteins, Disease Progression, Multimodal Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Imaging the evolution and pathophysiology of Alzheimer disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks